Literature DB >> 885613

Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis.

R D Diamond.   

Abstract

A model of cryptococcosis was developed using intraperitoneal infections of guinea pigs. This model shared characteristics with cryptococcosis in humans and was used to study the effects of immunosuppression and immunostimulation on cryptococcosis. Female guniea pigs survived longer than males; perphaps this was related to a greater capacity of their monocytes to kill cryptococci. A brief course of cortisone shortened survival of females and resulted in depressed immune and inflammatory responses, which persisted long after cortisone was stopped. Stimulation of the immune response by treatment with cryptococci in Freund complete adjuvant improved survival in males. Preliminary studies indicated the usefulness of this model for the study of other potential immunostimulants, including immune lymphocytes, transfer factor prepared from immune lymphocytes, and levamisole. Overall, long-term survivors appeared to clear disseminated cryptococci from extraperitoneal sites including brain, rather than prevent dissemination of cryptococci from the peritoneal cavity. The quantity of the inflammatory response in infectious foci, rather than the ability of individual leukocytes to kill crytococci, may have determined the outcome of most infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885613      PMCID: PMC421100          DOI: 10.1128/iai.17.1.187-194.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

2.  Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition.

Authors:  K E Powell; B A Dahl; R J Weeks; F E Tosh
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Suppression of the cellular interactions of delayed hypersensitivity by corticosteroid.

Authors:  W J Casey; C E McCall
Journal:  Immunology       Date:  1971-08       Impact factor: 7.397

5.  Serology of human cryptococcosis.

Authors:  D D Bindschadler; J E Bennett
Journal:  Ann Intern Med       Date:  1968-07       Impact factor: 25.391

6.  Corticosteroids and lymphoid cells.

Authors:  H N Claman
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

7.  Control for rheumatoid factor in the latex test for cryptococcosis.

Authors:  J E Bennett; J W Bailey
Journal:  Am J Clin Pathol       Date:  1971-09       Impact factor: 2.493

8.  Growth of Cryptococcus neoformans within human macrophages in vitro.

Authors:  R D Diamond; J E Bennett
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

9.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective foci.

Authors:  R J North
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

View more
  20 in total

1.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  A microsomal fraction of Cryptococcus neoformans induces lymphocyte blastogenesis in infected guinea pigs.

Authors:  A E Jones; E Reiss; T J Spira
Journal:  Mycopathologia       Date:  1981-09-11       Impact factor: 2.574

3.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans.

Authors:  P Y Fung; J W Murphy
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 5.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

6.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.

Authors:  R A Fromtling; H J Shadomy; A M Kaplan
Journal:  Mycopathologia       Date:  1984-03-15       Impact factor: 2.574

Review 8.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

9.  Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.

Authors:  S M Levitz; D J DiBenedetto
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis.

Authors:  J R Graybill; P C Craven; L F Mitchell; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.